LENSAR (LNSR) EBITDA Yield: History & Chart

LENSAR Inc(LNSR)

Medical - Devices · Orlando, FL

$6.73+0.06 (+0.90%)

Delayed quote: Oct 6, 2026, 11:04 AM EDT

About LENSAR Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Orlando, FL

150 employees

www.lensar.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Nicholas T. Curtis

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
LENSAR Inc (LNSR)	$82.66M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$82.66M	N/A	N/A	N/A	N/A
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$82.69M	N/A	N/A	N/A	N/A
MediciNova, Inc. (MNOV)vs ›	$83.18M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$81.02M	N/A	N/A	N/A	N/A
Atara Biotherapeutics, Inc. (ATRA)vs ›	$83.43M	N/A	17.90%	17.90%	17.90%
Cognition Therapeutics, Inc. (CGTX)vs ›	$84.58M	N/A	N/A	N/A	N/A
Humacyte, Inc. (HUMA)vs ›	$85.18M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$80.12M	N/A	N/A	N/A	N/A
Cardiff Oncology, Inc. (CRDF)vs ›	$85.55M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

LENSAR Inc (LNSR)

$82.66M

N/A

Nutriband Inc. (NTRB)vs ›

$82.66M

N/A

Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›

$82.69M

N/A

MediciNova, Inc. (MNOV)vs ›

$83.18M

N/A

Citius Oncology, Inc. (CTOR)vs ›

$81.02M

N/A

Atara Biotherapeutics, Inc. (ATRA)vs ›

$83.43M

N/A

17.90%

Cognition Therapeutics, Inc. (CGTX)vs ›

$84.58M

N/A

Humacyte, Inc. (HUMA)vs ›

$85.18M

N/A

Pulmonx Corporation (LUNG)vs ›

$80.12M

N/A

Cardiff Oncology, Inc. (CRDF)vs ›

$85.55M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

LNSR EBITDA Yield Metrics

LNSR Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics